Skip to main content
Equibles
SBRA logo

SBRA · Sabra Health Care REIT, Inc. · Metrics

Track SBRA — free

Use SBRA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SBRA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$20.79 -0.02 (-0.10%) At close · Sep 9
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.31B
Shares
255.46M

SBRA metrics

72 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$20.79
Market cap
$5.31B

Price action

20 metrics
Price change (1W)
-0.6%
Price change (30D)
+0.7%
Price change (3M)
+10.1%
Price change (6M)
0.0%
Price change (YTD)
+9.9%
Price change (1Y)
+8.4%
Trailing year
Price change (5Y)
+24.9%
52-week high
$22.39
52-week low
$17.23
Change from 52-week high
-7.1%
Change from 52-week low
+20.8%
Annualized volatility
24.3%
Annualized volatility (3M)
31.2%
Beta
-0.2
RSI (14D)
52.6
Price vs SMA 50
+0.9%
Price vs SMA 200
+4.7%
Avg volume (3M)
2.93M
Relative volume
0.8
Average dollar volume
$59.00M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
255.46M

Valuation

12 metrics
P / E (TTM)
80.0
Trailing earnings · reciprocal yield 1.2%
PEG ratio
—
EV / revenue
9.0×
reciprocal yield 11.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
6.2×
reciprocal yield 16.2%
P / book
1.9
reciprocal yield 51.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
14.3
reciprocal yield 7.0%
Earnings yield
1.2%

Historical valuation

8 metrics
P / E historical average (3Y)
61.6×
reciprocal yield 1.6%
P / E historical average (5Y)
61.6×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
9.2×
reciprocal yield 10.9%
EV / revenue historical average (5Y)
9.2×
reciprocal yield 10.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
5.8%
Trailing 12 months
Payout ratio
455.5%
Shareholder yield
5.6%
Dividend / share (TTM)
$1.20
Dividend growth YoY
+0.0%
Dividend growth streak
—
Last ex-dividend
2026-08-14

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
7.6%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
$65.44M
Trailing 12 months
Diluted EPS (TTM)
$0.26
FCF margin
—
Effective tax rate
3.5%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$11.21

Growth

11 metrics
Revenue growth YoY
+24.7%
Year over year
Net income growth YoY
-138.5%
Revenue (TTM)
$859.56M
Trailing 12 months
EPS growth YoY
-137.0%
Shares change YoY
+4.7%
Year over year · more shares
Revenue CAGR (3Y)
+7.4%
Revenue CAGR (5Y)
+5.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
-0.9%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
2.4%
Return on assets
1.2%
Debt / equity
1.0
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$2.39B
Latest balance sheet
Cash & equivalents
$231.58M
Total assets
$5.51B
Total debt
$2.63B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$371.57M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$13.13M
R&D / revenue
—
Stock compensation / revenue
1.5%

Ownership (13F)

3 metrics
13F filers
467
13F filer change QoQ
+4
Institutional ownership
102.2%

Short interest

3 metrics
Short interest
9.7%
Latest settlement · 8.7 days to cover
Days to cover
8.7d
Short-squeeze score
70 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$4.17M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1492298 CUSIP 78573L106 13F (30d) 256 filings 254 filers Visit website Investor relations